Feasibility of totally implantable venous access ports in the upper arm for patients with head and neck cancer in the modern era of chemotherapy
The Journal of Vascular Access · 2025
DOI: 10.1177/11297298241279623 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Vascular Access, 2025. Verfasst von Masakazu Ikeda und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, Fukushima Medical University, Fukushima City, Japan. Hauptthemen laut MEDLINE: Head and Neck Neoplasms, Catheters, Indwelling, Antineoplastic Agents, Catheterization, Central Venous. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Backgrounds: With recent developments in chemotherapy, the prognosis of head and neck cancer patients has been prolonged, and it is expected that totally implantable venous access devices will be developed for use as feasible and safe chemotherapy routes. We investigated the feasibility of implanting totally implantable venous access ports in the upper arms of head and neck cancer patients in this modern era of chemotherapy.
Methods
Relevant data of a cohort of 210 patients with head and neck cancer who had had totally implantable venous access devices implanted between January 2013 and December 2022 were investigated retrospectively. The totally implantable venous access ports were used for chemoradiotherapy, chemotherapy, radiotherapy, and palliative treatment. Adverse events related to totally implantable venous access devices were investigated and the associated variables subjected to statistical analysis.
Results
There were 22 (10.5%) adverse events, representing 0.201 adverse events per 1000 catheter days. Non-ultrasound-guided puncture ( p = 0.015) and forearm implantation ( p = 0.005) were associated with higher risk of adverse events according to univariate analysis. According to multiple logistic analysis, non-ultrasound-guided puncture was significantly associated with age and sex (OR = 2.89; 95% CI, 1.14, 7.36; p = 0.026).
Conclusion
Peripherally implanted totally implantable venous access devices in the upper arm are feasible and safe for head and neck cancer patients. Ultrasound-guided implantation of totally implantable venous access ports into the upper arms of head and neck cancer patients may reduce the adverse event rate.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology, Fukushima Medical University, Fukushima City, Japan.
- Department of Head and Neck Surgery and Otolaryngology, Asahi University Hospital, Gifu, Japan.
- Department of Hygiene and Preventive Medicine, School of Medicine, Fukushima Medical University, Fukushima City, Japan.
ORCID-Profile: Masakazu Ikeda
Zitieren
APA
Ikeda, M., Matsuzuka, T., Kakamu, T., Nakaegawa, Y., Kawase, T., Saito, Y., Kubota, S., Imaizumi, M., & Murono, S. (2025). Feasibility of totally implantable venous access ports in the upper arm for patients with head and neck cancer in the modern era of chemotherapy. The Journal of Vascular Access. https://doi.org/10.1177/11297298241279623
Vancouver
Ikeda M, Matsuzuka T, Kakamu T, Nakaegawa Y, Kawase T, Saito Y, et al. Feasibility of totally implantable venous access ports in the upper arm for patients with head and neck cancer in the modern era of chemotherapy. The Journal of Vascular Access. 2025. doi:10.1177/11297298241279623
BibTeX
@article{Ikeda2025,
author = {Ikeda, Masakazu and Matsuzuka, Takashi and Kakamu, Takeyasu and Nakaegawa, Yuta and Kawase, Tomotaka and Saito, Yukiko and Kubota, Satoshi and Imaizumi, Mitsuyoshi and Murono, Shigeyuki},
title = {Feasibility of totally implantable venous access ports in the upper arm for patients with head and neck cancer in the modern era of chemotherapy},
journal = {The Journal of Vascular Access},
year = {2025},
doi = {10.1177/11297298241279623}
}
EUVIMED